SAFE-BioPharma Receives Safe Harbor Certification

SAFE-BioPharma Association has certified compliance with the US Department of Commerce and European Union Safe Harbor requirements for the protection of personal data. The non-profit association developed and manages the global SAFE-BioPharma® digital identity and signature standard, used within the biopharmaceutical and healthcare industries.

To qualify, SAFE-BioPharma developed its privacy policy to comply with the E.U.’s Safe Harbor Principles. Safe Harbor Certification will enable SAFE-BioPharma to transfer personal data outside the E.U., expediting the flow of information between European clients and the United States. The certification recognizes that SAFE-BioPharma’s privacy and data security policies provide "adequate protection" for personal data from its European clients as required by the European Union's Data Protection Directive.

“Receiving Safe Harbor status assures SAFE-BioPharma member companies that use of the standard to manage digital identities and/or to apply digital signatures is consistent with E.U. regulations regarding data transfer and will further enhance our capabilities to better serve our European clients,” said Mollie Shields-Uehling, President and CEO, SAFE-BioPharma Association.

Details regarding E.U. Safe Harbor Principles are available at

About SAFE-BioPharma Association ( SAFE-BioPharma Association is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.

The SAFE-BioPharma industry standard is used to mitigate legal, regulatory and other business risk associated with business-to-business and business-to-regulator electronic transactions. It facilitates interoperability by providing a secure, enforceable, and regulatory-compliant way to verify identities of parties involved in electronic transactions. Because the standard is linked to the Federal Bridge PKI Architecture through the 4BF (, a SAFE-BioPharma digital identity can be trusted by any Federal agency. SAFE-BioPharma’s vision is to be a catalyst in transforming the biopharmaceutical and healthcare communities to a fully electronic business environment by 2012.

The Association’s members include:

SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.


SAFE-BioPharma Association
Jon Weisberg
M 801-860-9977
O 801-359-9977

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.